EP3518960
Skammtaáform fyrir PTH efnasamband með stýrða losun
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
28.9.2017EP published:
19.7.2023EP application number:
17781425.8
EP translation filed:
18.9.2023Grant published:
15.10.2023EPO information:
European Patent Register
Max expiry date:
27.9.2037Expiry date:
27.9.2026Next due date:
30.9.2026
Title in English:
DOSAGE REGIMEN FOR A CONTROLLED-RELEASE PTH COMPOUNDLanguage of the patent:
English
Timeline
Today
28.9.2017EP application
19.7.2023EP Publication
18.9.2023Translation submitted
15.10.2023Registration published
27.9.2026Expires
Owner
Name:
Ascendis Pharma Bone Diseases A/SAddress:
Tuborg Boulevard 12, 2900 Hellerup, DK
Inventor
Name:
HOLTEN-ANDERSEN, LarsAddress:
2900 Hellerup, DK
Name:
SPROGØE, KennettAddress:
2900 Hellerup, DK
Name:
KARPF, David BrianAddress:
Palo Alto, CA 94304, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
16191451Date:
29.9.2016Country:
EP
Number:
17155843Date:
13.2.2017Country:
EP
Classification
Categories:
A61K 38/29, A61K 9/00, A61K 47/34, A61P 5/18, A61P 7/00, A61P 7/04, A61P 17/14, A61P 19/02, A61P 19/08, A61P 19/10, A61P 29/00, A61K 9/16
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 20.9.2023
Expires: 27.9.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 17.9.2024
Expires: 27.9.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 24.9.2025
Expires: 27.9.2026
Payer: Árnason Faktor ehf.